Global Bone Cancer Drugs Market 2019-2023
SKU ID : TNV-14141980 | Publishing Date : 12-Apr-2019 | No. of pages : 125
Detailed TOC of Global Bone Cancer Drugs Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY INDICATION
• Market segmentation by indication
• Comparison by indication
• Osteosarcoma - Market size and forecast 2018-2023
• Ewing's sarcoma - Market size and forecast 2018-2023
• Chondrosarcoma - Market size and forecast 2018-2023
• Others - Market size and forecast 2018-2023
• Market opportunity by indication
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Amgen
• Bayer AG
• Bristol-Myers Squibb Company
• Merck & Co. Inc.
• Pfizer Inc.
PART 15: APPENDIX
• Research methodology
• List of abbreviations
• Definition of vendors classification
PART 16: EXPLORE TECHNAVIO
Exhibit 01: Global oncology therapeutics market
Exhibit 02: Segments of global oncology therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Global bone cancer drugs market pipeline: Overview
Exhibit 18: Global bone cancer drugs market pipeline: Snapshot
Exhibit 19: Indication - Market share 2018-2023 (%)
Exhibit 20: Comparison by indication
Exhibit 21: Osteosarcoma - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Osteosarcoma - Year-over-year growth 2019-2023 (%)
Exhibit 23: Ewing's sarcoma - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Ewing's sarcoma - Year-over-year growth 2019-2023 (%)
Exhibit 25: Chondrosarcoma - Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Chondrosarcoma - Year-over-year growth 2019-2023 (%)
Exhibit 27: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Others - Year-over-year growth 2019-2023 (%)
Exhibit 29: Market opportunity by indication
Exhibit 30: Customer landscape
Exhibit 31: Market share by geography 2018-2023 (%)
Exhibit 32: Geographic comparison
Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: North America - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in North America
Exhibit 36: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Europe
Exhibit 39: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in Asia
Exhibit 42: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 43: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 44: Top 3 countries in ROW
Exhibit 45: Key leading countries
Exhibit 46: Market opportunity
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Vendor landscape
Exhibit 49: Landscape disruption
Exhibit 50: Vendors covered
Exhibit 51: Vendor classification
Exhibit 52: Market positioning of vendors
Exhibit 53: Amgen - Vendor overview
Exhibit 54: Amgen - Business segments
Exhibit 55: Amgen - Organizational developments
Exhibit 56: Amgen - Geographic focus
Exhibit 57: Amgen - Key offerings
Exhibit 58: Amgen - Key customers
Exhibit 59: Bayer AG - Vendor overview
Exhibit 60: Bayer AG - Business segments
Exhibit 61: Bayer AG - Organizational developments
Exhibit 62: Bayer AG - Geographic focus
Exhibit 63: Bayer AG - Segment focus
Exhibit 64: Bayer AG - Key offerings
Exhibit 65: Bayer AG - Key customers
Exhibit 66: Bristol-Myers Squibb Company - Vendor overview
Exhibit 67: Bristol-Myers Squibb Company - Business segments
Exhibit 68: Bristol-Myers Squibb Company - Organizational developments
Exhibit 69: Bristol-Myers Squibb Company - Geographic focus
Exhibit 70: Bristol-Myers Squibb Company - Key offerings
Exhibit 71: Bristol-Myers Squibb Company - Key customers
Exhibit 72: Merck & Co. Inc. - Vendor overview
Exhibit 73: Merck & Co. Inc. - Business segments
Exhibit 74: Merck & Co. Inc. - Organizational developments
Exhibit 75: Merck & Co. Inc. - Geographic focus
Exhibit 76: Merck & Co. Inc. - Segment focus
Exhibit 77: Merck & Co. Inc. - Key offerings
Exhibit 78: Merck & Co. Inc. - Key customers
Exhibit 79: Pfizer Inc. - Vendor overview
Exhibit 80: Pfizer Inc. - Business segments
Exhibit 81: Pfizer Inc. - Organizational developments
Exhibit 82: Pfizer Inc. - Geographic focus
Exhibit 83: Pfizer Inc. - Segment focus
Exhibit 84: Pfizer Inc. - Key offerings
Exhibit 85: Pfizer Inc. - Key customers
Exhibit 86: Validation techniques employed for market sizing
Exhibit 87: Definition of vendors classification
Keyplayers in Global Bone Cancer Drugs Market 2019-2023
AmgenBayer AG
Bristol-Myers Squibb Company
Merck & Co. Inc.
Pfizer Inc.